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The melanocyte lineage in development and disease
Richard L. Mort1, Ian J. Jackson1,2,* and E. Elizabeth Patton1,3
ABSTRACT
Melanocyte development provides an excellent model for studying
more complex developmental processes. Melanocytes have an
apparently simple aetiology, differentiating from the neural crest and
migrating through the developing embryo to specific locations within
the skin and hair follicles, and to other sites in the body. The study of
pigmentation mutations in the mouse provided the initial key to
identifying the genes and proteins involved in melanocyte
development. In addition, work on chicken has provided important
embryological and molecular insights, whereas studies in zebrafish
have allowed live imaging as well as genetic and transgenic
approaches. This cross-species approach is powerful and, as we
review here, has resulted in a detailed understanding of melanocyte
development and differentiation, melanocyte stem cells and the role
of the melanocyte lineage in diseases such as melanoma.
KEY WORDS: MITF, Melanoma, Neural crest, Stem cells
Introduction
Melanin, the pigment that colours the skin, eyes, hair, fur, feathers and
scales of vertebrates (see Box 1), is made by specialised cells called
melanocytes. Some animals, such as birds, fish and reptiles, have
additional cells that make other pigments that, through reflection and
refraction, display a wide variety of colours, but melanocytes are
ubiquitous across vertebrates. Studies ofmelanocyte biology played a
major role in the birth of genetics. In the first genetic experiments in
animals, for example, Cuenot (1902) used crosses of unpigmented
albino mice to confirm Mendel’s Laws. Genetics has continued to
play an important role in aiding our understanding of melanocyte
biology. Most notably, there are almost 200 genes identified in mice
that play a role in pigment biology, and numerous genes in other
species, in particular zebrafish, that together govern melanocyte
development and cell biology.
Melanocytes and their progenitor cells, melanoblasts, have also
long been of particular interest to developmental biologists. They
provide an excellent model for development: they are a single cell
type that differentiates from a multipotential stem cell, they migrate
through the developing embryo and interact with their environment
to localise to specific sites in the body, and they generate a stem cell
population through which they self-renew. These properties might
be one of the reasons that melanoma, the cancer originating from
melanocytes, is particularly aggressive and metastatic. In this
Review, we bring together recent work from mice, birds and
zebrafish that together provide a powerful cross-species perspective
on melanocyte development and cancer biology. We review the
transcriptional regulation of the development of melanoblasts and
melanocytes, and how their migration is controlled. Furthermore,
we review recent advances made in understanding the biology of
melanocyte stem cells (MSCs), which aid our understanding of the
biology of stem cells in general. Finally, we discuss how our
knowledge of melanocyte biology has informed research on
melanoma and is contributing to the design of new treatment
strategies.
The neural crest and the origins of the melanocyte lineage
The melanocyte lineage is derived from the neural crest, which has
its origins in the neural tube. Following its formation, neural crest
cells delaminate from the dorsal-most aspect of the neural tube by a
process of epithelial-to-mesenchymal transition. These neural crest
cells are highly migratory and go on to form many specialised
structures and tissues in the developing embryo by migration,
proliferation and differentiation (Mayor and Theveneau, 2013). The
antero-posterior position at which neural crest cells delaminate
broadly defines their fate and, based on this positioning, the neural
crest can be subdivided into five overlapping groups: cranial, vagal,
sacral, trunk and cardiac. The neural crest in the trunk region gives
rise to, among others, melanocytes, neurons and glia. Elegant work
using avian grafts demonstrated that cells that leave the crest early
follow a ventral migration path through the anterior sclerotome and
become neurons and glia, whilst late departing cells follow a
dorsolateral pathway between the ectoderm and the somites through
the developing dermis and become melanocytes (Erickson and
Goins, 1995). The fate of the cells is not determined by their
migratory path, but rather the cells are specified before leaving the
Box 1. Melanosomes and melanin production
Melanin is a macromolecule synthesised by melanocytes. The first step
in melanin synthesis is catalysed by the enzyme tyrosinase, which
converts tyrosine to dihydroxyphenylalanine (DOPA). The lack of this
enzyme results in albinism. Melanin in mammals and birds comes in two
forms: eumelanin, which is black or dark brown, and phaeomelanin,
which is red or yellow. The biosynthetic pathways for the two pigments
diverge downstream of DOPA, and the choice of pathway is determined
by the signalling activity of the melanocortin receptor MC1R. The
biosynthetic intermediates of melanogenesis are toxic, which is perhaps
one reason why the synthesis occurs in a specialised organelle, a
modified lysosome known as melanosome. Most melanocytes do not
retain melanin, but rather the melanin granules are transported along
microtubules to the tips of dendrites, long cell protrusions, from where
they are transferred to nearby keratinocytes in the skin, hair or feather.
The situation in fish is somewhat different: melanocytes only produce
eumelanin and the melanin granules are retained by the cell. MC1R
activity in fish produces a movement of the melanin granules out along
microtubules, which results in a darkening of the fish as camouflage. The
reverse movement of melanin into the centre of the fish melanocyte is
produced via a different signalling system involving the melanin-
concentrating hormone (MCH) receptor.
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crest. By isolating single migratory neural crest cells and allowing
their differentiation in vitro, it was shown that, whilst some isolated
cells could give rise to mixed clones containing neurons, glia and
melanocytes, and others were fated to produce only a single cell
type, two other major mixed-fate cells were identified: some cells
were progenitors of glia and neurons, whilst others could produce
glia and melanocytes (Henion and Weston, 1997). Furthermore,
Schwann cells, which are the glial cells of the peripheral nervous
system, can be dedifferentiated in vitro to a glia/melanocyte
precursor (Dupin et al., 2003). The fate map is thus slightly
complicated, with glia seeming to have two different origins. Recent
work, discussed in detail below, also suggests a dual neural crest
origin of melanocytes, one by early differentiation from the neural
crest and dorsolateral migration, and the other from a Schwann cell
(glial)/melanoblast progenitor on the ventral path.
Transcriptional regulation of melanocyte identity
The transcription factor microphthalmia-associated transcription
factor (MITF) appears to be the master regulator of melanocyte
identity and is embedded within a transcriptional network (Fig. 1)
that controls the development of melanocytes from the neural crest
[reviewed by Baxter et al. (2010)]. Mice lacking MITF cannot form
melanocytes (Steingrímsson et al., 2004). Similarly, fish lacking
one of the MITF orthologues, mitfa, have no melanocytes, and
ectopic expression ofmitfa can produce ectopic melanocytes (Lister
et al., 1999). Furthermore, the expression of MITF in Medaka
embryo-derived stem cells induces differentiation into melanocytes
(Béjar et al., 2003), and MITF expression in NIH3T3 cells can
activate melanocyte markers (Tachibana et al., 1996). Numerous
MITF transcriptional targets have been identified, and include
genes encoding components of melanocyte-specific organelles
(melanosomes) and the melanin synthesis pathway (see Box 1) as
well as more widely expressed genes such as the survival gene Bcl2
(Cheli et al., 2010). In humans, germline mutations in MITF can
lead to Waardenburg syndrome or Tietz syndrome [Online
Mendelian Inheritance in Man database (OMIM) entries 193510
and 103500, respectively], which are characterised by lack of
pigmentation and deafness, as melanocytes also play an important
function in the ear. In addition, more subtle changes in MITF
transcriptional activity regulated by IRF1 are partially responsible
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Fig. 1. An overview of melanocyte development. (A) In mammals, melanoblasts are specified from neural crest cells (NCCs) via a SOX10-positive
melanoblast/glial bipotent progenitor. SOX10 expression remains switched on in both of these lineages. Melanoblasts subsequently are specified and acquire
MITF, DCT and KIT expression. After colonising the developing embryonic hair follicles, some melanoblasts differentiate into melanocytes and produce the
pigment (melanin) that colours the first hair cycle. A subset of melanoblasts dedifferentiate (losingMITFand KITexpression but not DCT) to formmelanocyte stem
cells in the hair follicle bulge that replenish the differentiatedmelanocytes via a rapidly proliferating transit-amplifying cell in the subsequent hair cycles. The image
on the far right is of a transgenic mouse embryo expressing lacZ under control of the melanoblast promoterDct. X-Gal staining reveals blue-stainedmelanoblasts,
in particular those migrating from the cervical neural crest and in the head. Also stained are the telencephalon, the dorsal root ganglia (DRG) and the retinal
pigmented epithelium of the eye. (B) In zebrafish, there are distinct embryonic and adult pigmentation patterns, as illustrated in the images on the far right. The
melanoblasts that form both these patterns originate from a SOX10-positive neural crest-derived progenitor. The embryonic pattern is formed bymelanocytes that
develop directly from this progenitor via an MITF+ melanoblast. The melanoblasts that form the adult pattern are derived from a melanocyte stem cell population
that resides at the dorsal route ganglia (DRG) and is specified by an ERB- and KIT-dependent pathway in the embryo.
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for the pale skin, blue eyes and freckling with brown hair seen in
some Northern European populations (Praetorius et al., 2013).
The key step during melanocyte formation is thus the activation of
MITF. But how is this achieved? Gene expression studies show that
WNT3A is upregulated and bone morphogenetic protein 4 (BMP4)
downregulated coincident with melanoblast specification in the
quail neural crest, and that WNT3A induces melanoblast formation
in quail neural crest cultures (Jin et al., 2001). Furthermore, the
addition of WNT3A to mouse melanocytes in culture induces the
expression of MITF (Takeda et al., 2000). Clues to the
transcriptional mechanism by which MITF is activated came
initially from mouse and human genetics. Mutations in either of
two genes, PAX3 or SOX10 (OMIM entries 606597 and 602229,
respectively), in humans result in Waardenburg syndrome and a
reduction in melanocytes, similar to mutations in MITF, and mice
mutant in either gene also lack melanocytes (Tachibana et al.,
2003). Both genes also affect the enteric nervous system due to a
deficit of neural crest-derived cells (Tachibana et al., 2003).
It was further shown that PAX3 and SOX10 act synergistically to
activate MITF transcription (Potterf et al., 2000; Watanabe et al.,
2002; Bondurand et al., 2000). However, mutant phenotypes and
gene expression studies indicate that these transcription factors also
specify glial cells, so how are the glial and melanocyte lineages
differentiated? Studies suggest that two further transcription factors,
FOXD3 and SOX2, play pivotal roles. FOXD3 is expressed in the
migrating neural crest cells that give rise to glia and neurons, but is
not seen in the later migrating, melanocyte-fated crest cells. The
knockdown of FOXD3 expression in avian neural crest in culture or
in vivo results in an increase in cells following the melanocyte
lineage, whilst FOXD3 overexpression in vivo suppresses
melanocyte formation (Kos et al., 2001). In addition, the
conditional knockout of Foxd3 in mice, using Wnt1-Cre to ablate
the gene specifically in the neural crest, results in MITF-positive
cells that are located along developing nerves in the embryo,
suggesting that glial-fated cells have been switched to the
melanocyte lineage (Nitzan et al., 2013a). FOXD3 acts in the
sameway in the later differentiating melanoblasts of chick embryos,
which share a Schwann cell lineage (Nitzan et al., 2013b).
Exploring the mechanism of this switch, Thomas and Erickson
(2009) demonstrated that FOXD3, in mouse melanoma cells or in
quail neural crest cells, repressed MITF expression even in the
presence of PAX3 and SOX10. This repression appears to act via a
highly conserved motif in the melanocyte-specific promoter of
MITF, which contains PAX3 and SOX10 binding sites. Curiously,
however, chick FOXD3 does not bind to this element, at least in
vitro; rather, its repressive activity comes about by a mechanism that
is independent of DNA binding. FOXD3 interacts with PAX3 and
prevents the latter binding to and activating the MITF promoter.
Indeed, a modified FOXD3 protein, containing a transcription
activation domain rather than a repressor domain, still repressed
MITF transcription in melanoma cells. However, in contrast to these
conclusions, repression of zebrafish mitfa transcription by FOXD3
is direct; there are FOXD3 binding sites in the zebrafish mitfa
promoter through which repression is mediated, and the DNA-
binding domain of zebrafish FOXD3 is necessary for the repression
of transcription in transfected mouse melanoma cells or in
fibroblasts co-transfected with SOX10 (Curran et al., 2010, 2009).
Very similar results are seen when SOX2 is upregulated or knocked
out in chick or mouse embryos. SOX2 binds to the promoter of
MITF and represses its expression in vitro. In line with this, the
conditional deletion of Sox2 in mouse neural crest cells results in a
glia-to-melanoblast fate switch, whereas the overexpression of
SOX2 in chick embryos leads to a loss of MITF-positive cells
(Adameyko et al., 2012).
The trigger for the melanoblast lineage therefore appears to be
downregulation of FOXD3 and/or SOX2 in the glia/melanocyte
common progenitor. How exactly this is initiated is unclear,
although histone deacetylase 1 seems to be important for repressing
sox10 and foxd3 expression in the melanocyte lineage in zebrafish
(Ignatius et al., 2008; Greenhill et al., 2011). It is also known that the
expression of FOXD3 in the neural crest initially seems to be
triggered by ZIC1 and PAX3 (Plouhinec et al., 2014), but is later
maintained by SNAIL2 and SOX9 (Nitzan et al., 2013a). There thus
appears to be a transcriptional hierarchy in which SNAIL2 activates
SOX9, which in turn activates FOXD3. Thus, persistent expression
of SNAIL2 in chick embryos results in the persistence of SOX9 and
FOXD3 expression, and the persistence of SOX9 also gives
continuous expression of FOXD3, but not SNAIL2. Consistently,
the expression of dominant negative forms of either SNAIL2 or
SOX9 leads to a downregulation of FOXD3 (Nitzan et al., 2013a).
In addition, ectopic expression of MITF in glial-fated neural crest
cells in chick embryos downregulates SNAIL2, SOX9 and FOXD3,
suggesting a mechanism by which, once MITF has been activated,
there is feedback to reinforce the stability of the melanocyte fate that
it programmes. A similar cross-repression mechanism also applies
to SOX2; ectopic expression of MITF, induced by doxycycline in
chick embryos, leads to rapid downregulation of SOX2 and
reinforces the melanoblast fate induced by MITF (Adameyko
et al., 2012).
Melanoblast development andmigration in mouse and chick
embryos
In order to colonise the epidermis and to completely populate the
developing hair follicle field, specified melanoblasts must
proliferate to increase their numbers and migrate over large
distances. At embryonic day (E) 10.5 in mice, there are fewer
than 100 melanoblasts in the trunk region, but by E15.5 this has
increased to around 20,000 (Luciani et al., 2011). In organotypic
cultures, E14.5 mouse melanoblasts proliferate and appear to
migrate randomly at speeds in the order of 0.5 µm min−1 (Mort
et al., 2010). Failure to migrate or proliferate sufficiently results in
the unpigmented patches seen in humans (Fleischman et al., 1991),
numerous mouse mutants (Lamoreux et al., 2010) and also in the
selectively bred piebald patterns of domestic animals, such as horses
and cows (Hauswirth et al., 2012; Fontanesi et al., 2010). As we
discuss below, recent studies have begun to identify various
populations of melanoblasts and the factors and mechanisms that
regulate their migration.
The dorsolaterally migrating melanoblast population
Melanoblast precursors delaminate at around E9 in mouse
embryos and begin to express the specific markers Mitf, Dct and
Pmel, and from E10.5 (Baxter and Pavan, 2003; Nakayama et al.,
1998; Mackenzie et al., 1997) they begin to migrate dorsolaterally
through the developing embryo (Fig. 2A). In chick embryos,
neural crest migration in the trunk begins at Hamburger–Hamilton
stage (HH) 12-13 (Loring and Erickson, 1987). Although ventral
migration begins immediately, melanoblasts appear to pause in a
region between the somites and the neural tube termed the
migration staging area (MSA) before embarking on the
dorsolateral pathway from stage 20 (Erickson et al., 1992;
Weston, 1991; Wehrle-Haller and Weston, 1995). This
dorsolateral migration can be visualised in chimaeras between
pigmented and unpigmented mouse embryos, and in retrovirally
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rescued tyrosinase-expressing mosaic mice, which exhibit broad
bands of colour extending dorsolaterally in the adult coat (Huszar
et al., 1991; McLaren and Bowman, 1969; Mintz, 1967). The
stripes exhibit sharp mid-dorsal separation, indicating that the two
sides of the embryo are specified separately. These patterns have
been thought to represent clones of migrating melanoblasts that
originate from a small number of precursors, but there is a
surprising amount of mixing at the axial level between adjacent
melanoblast clones, making a prediction of the precise number of
progenitors problematic (Wilkie et al., 2002).
Although not required for the initial specification of
melanoblasts, endothelin receptor type B (EDNRB; a G-protein-
coupled receptor expressed by melanoblasts) and its ligand
endothelin B are required for melanoblast migration and
proliferation in the dermis between E10.5 and E12.5 (Lee et al.,
2003; Shin et al., 1999). If EDNRB2 (one of the two chick EDNRB
orthologues) is mis-expressed in early chick neural crest cells, they
shift their migration path from ventral to dorsolateral (Krispin et al.,
2010), although in the mouse, Ednrb is expressed in neural crest
cells on both dorsal and ventral pathways.
Changes in the expression of cell adhesion molecules are also
required for migration. For example, pre-migratory neural crest
populations express the calcium-dependent adherens junction
protein N-cadherin, but this is downregulated upon upregulation of
SLUG (in chicken) or Snail (in mice) during the epithelial-to-
mesenchymal transition (Nieto et al., 1994; Jiang et al., 1998).
Furthermore, at E11.5 in mice, most dermal melanoblasts are E-
and P-cadherin negative but, over the next 48 h, there is a 200-fold
increase in cadherin expression such that the majority of
melanoblasts become E-cad high/P-cad low, concomitant with
their migration from the dermis to the epidermis (from E12.5 in
mice, HH22 in chick) (Nishimura et al., 1999). It should be noted
that crossing from the dermis to the epidermis is an active process
but does not require degradation of the basement membrane (Li
et al., 2011). By E13.5 the majority of melanoblasts are epidermal
and continue to migrate and proliferate in an EDNRB-independent
manner. However, not all melanoblasts cross the dermal/epidermal
junction and a dermal population also persists. This process is
clearly regulated and, although dermal melanoblasts are
proliferating, their numbers remain unchanged, indicating a
constant and controlled dermal-to-epidermal movement (Luciani
et al., 2011). Furthermore, in mice with mutations that cause an
expansion of the early melanoblast population, the number of
melanocytes reaching the epidermis appears to be unchanged
whilst the number of dermal melanocytes increases, thereby
resulting in dark skin (Van Raamsdonk et al., 2004), suggesting a
mechanism for controlling the size of the epidermal melanoblast
population.
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Fig. 2. Development of the melanocyte lineage. (A) In mouse and chick embryos, early melanoblasts are derived from the neural crest and migrate
dorsolaterally through the dermis between the somites and the developing epidermis. At later stages, they become epidermal, and a second wave is thought to
differentiate from Schwann cell precursors associated with developing nerves, contributing to the adult melanocytes of the trunk, head and developing limbs. It is
not clear whether the late population intercalates with or replaces the early population. (B) In zebrafish embryos, melanocytes migrate dorsolaterally and
along nerves ventrally (purple) to form the embryonic pattern. Melanocyte stem cells (MSCs) are located at the DRG (marked by asterisk). Following
metamorphosis or melanocyte ablation of the embryonic pattern, zebrafish glial-pigment cell progenitors proliferate and migrate along nerves to form the adult
melanocyte stripes. MSCs specified in the developing embryo are the proposed source of metamorphic melanocytes of the adult. Adapted from Adameyko et al.
(2009); Dooley et al. (2013); Dupin and Sommer (2012). NT, neural tube; N, notochord; dm, dermamyotome; DRG, dorsal root ganglia; S, somite; D, dorsal; V,
ventral; L, lateral; M, medial.
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The receptor tyrosine kinase KIT and its ligand (KITL) are
required for the survival, migration and proliferation of embryonic
melanoblasts throughout their migration along the dorsolateral
pathway (Yoshida et al., 1996). Mutations in the mouse genes
encoding this receptor/ligand pair, which lie within the classical
dominant white spotting (W ) and steel (Sl) loci, can result in an
absence of melanocytes as well as other developmental defects.
KITL occurs in two forms: a secreted, soluble protein and a
membrane-bound form found on the surface of keratinocytes in the
developing mouse epidermis. In mice, the membrane-bound ligand
is absolutely required by migrating dermal and epidermal
melanoblasts, regulating their survival and adhesion to the
intraepithelial niche (Tabone-Eglinger et al., 2012). Neither form
ofKITL is required for the specification ofmelanoblasts or to initiate
migration onto the dorsolateral pathway. Dorsolateral entry is,
however, preceded by the transient expression of KITL in
dermatomal epithelial cells (Wehrle-Haller and Weston, 1995).
Signalling throughKIT has also been shown to facilitatemelanoblast
migration and survival through independent mechanisms; migration
does not require RAS activity downstream of KIT, whereas survival
does (Wehrle-Haller et al., 2001).
A ventrally migrating population of melanocytes
As discussed above, melanocytes and glia can be derived from a
common bipotent neural crest precursor. However, recent evidence
suggests that a subpopulation of adult melanocytes in the trunk
originates from precursor cells that have Schwann cell/melanoblast
bipotential and have migrated on the ventrolateral pathway down the
developing nerve sheath. For example, Adameyko et al. (2009)
show that, in both chick and mouse embryos, there is a loss of
MITF/SOX10-positive melanoblasts from the dorsolateral pathway
between E10.5/HH24 and E11.5/HH27, and that these cells are
replaced by a second wave of neural crest-derived MITF/SOX10-
positive melanoblasts that arise in close proximity to the distal,
ventral ramus of the spinal nerve at E12/HH22. If the chick
ventrolateral pathway is physically ablated, this late differentiating
population is lost, but if the dorsolateral pathway is ablated, it is not.
Others have also demonstrated this ventrally migrating melanoblast
population in chick embryos (Nitzan et al., 2013b), in which there is
more spatial segregation; the dorsally migrating melanocytes
populate the epaxial dermis (which is derived from the somatic
mesoderm), whilst the ventrally migrating, later differentiating
population colonises the hypaxial dermis (which is derived from the
lateral plate mesoderm). Whether such a spatial separation of
melanocyte progenitors occurs in the mouse is not known; indeed, if
and where a distinction between hypaxial and epaxial dermis exists
in mice is unknown. In their study, Adameyko and colleagues use
Plp-CreErt2 (Leone et al., 2003) to lineage-mark Schwann cell
precursors (SCPs) following tamoxifen injection (Adameyko et al.,
2009). Using this approach, they show that a tamoxifen dose at E11
does not mark dorsolateral melanoblasts but does mark the SCP
lineage, and that, by P11, 65% of melanocytes in hair follicles can
be traced back to these SCPs. It is unclear whether the unlabelled
hair follicle melanocytes are derived from SCPs as well but were not
efficiently labelled by tamoxifen, or whether they are derived from
dorsolaterally migrating cells.
The situation in the head is more complicated, and studies
of Dct-lacZ-labelled rostrally migrating E10.5 melanoblasts
(Mackenzie et al., 1997) and Pmel17-labelled laterally migrating
E9.5 melanoblasts (Baxter and Pavan, 2003) suggest that several
overlapping cranial populations of melanoblasts are probably
present. In line with this, Adameyko and colleagues demonstrate
(again using Plp-CreERT2) a lineage relationship between SCPs
and early migrating cranial melanoblasts, but also describe a late
migrating population that is not associated with nerves or related
by lineage to SCPs (Adameyko et al., 2012). However, it should be
noted that the use of Plp-CreERT2 as an SCP-specific lineage
tracer must be evaluated carefully, as it is the key tool in the mouse
experiments. Transcriptomic analyses of mouse melanoblasts at
E15.5 show that they also express PLP (Colombo et al., 2012),
whereas Hari and co-workers showed that Plp-CreERT2 is active
in both nerves and melanoblasts at embryonic stages E11.5, E12.5
and E14.5 (Hari et al., 2012). They further show that Desert
hedgehog Cre (Dhh-Cre) (Jaegle et al., 2003), another proposed
SCP marker, does not label melanoblasts or future melanocytes in
the mouse. Furthermore, the transplantation studies of Rawles
(1940, 1947) and Mayer (1973) suggest that functional
melanoblast populations, able to colonise graft and host tissue,
are present in the dermis at E11 and in the dermis and epidermis at
E12, overlapping the window in which Adameyko et al. suggest
melanoblasts in the dorsolateral aspect become absent (Adameyko
et al., 2009). Thus, whilst the common embryonic origin of
melanocytes and glia, and the plasticity of the adult Schwann cell,
are not in doubt, further work, using alternative approaches to Plp-
CreERT2, is required to dissect the developmental timings and
lineage relationships of melanoblasts and SCPs in the developing
mouse embryo.
Cellular and molecular mechanisms of melanoblast migration
Recent advances in imaging techniques have allowed the
observation of melanoblast behaviour in the developing skin
using live confocal imaging (Mort et al., 2010, 2014). These
approaches have furthered our understanding of melanoblast
behaviour at the single-cell and collective level and have provided
insights into the regulation of migration and proliferation. Notably,
these studies have focused on key players in cytoskeletal
organisation and cell migration, such as RAC1, Fascin1,
Lamellipodin and the Scar/WAVE complex (Li et al., 2011; Law
et al., 2013; Ma et al., 2013).
RAC1 is the main mammalian isoform of RAC and controls actin
cytoskeletal assembly mediated by Scar/WAVE and ARP2/3 to
drive actin nucleation, and by PAK and LIM kinases to drive the
turnover of actin (Delorme et al., 2007; Insall and Machesky, 2009).
Melanoblast-specific ablation of Rac1 in mice leads to migratory
defects and problems with cell cycle progression and cytokinesis,
resulting in unpigmented patches at both dorsal and ventral
positions (Li et al., 2011). Live imaging of melanoblast migration
in Rac1 mutants reveals that melanoblasts mediate their migration
using long and short protrusions called pseudopods and stubs,
respectively. RAC1 regulates the frequency of pseudopod assembly
(Li et al., 2011). Similarly, ablation of the Rac-specific Rho GTPase
GEF Prex1 results in a belly spotting phenotype (Lindsay et al.,
2011). Neither Prex1 nor Rac1 mutant phenotypes can be rescued
by a constitutively active N-RAS, suggesting that proliferation alone
is not driving the phenotype (Lindsay et al., 2011; Li et al., 2012).
The Scar/WAVE complex is an effector of RAC1 signalling and, in
line with this, studies show that the Scar/WAVE complex, in
association with lamellipodin (Lpd), regulates melanoblast
migration in mice (Law et al., 2013). Melanoblast-specific
ablation of Fascin1, a scaffolding protein that is involved in the
bundling of actin filaments, is found in both filopodia and
invadopodia (Li et al., 2010a; Schoumacher et al., 2010), and is
often found in migrating embryonic cells; it also results in a mild
belly spotting phenotype and hypopigmentation at the tip of the tail
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and in the feet (Ma et al., 2013). In these mutants, a delay in cell
cycle progression and a reduction in melanoblast number as well as
a reduction in pseudopod generation rate (and therefore motility)
results in a failure of melanoblasts to fully populate the dorso-
ventral axis (Ma et al., 2013).
Surprisingly, the phenotypes in melanoblast-specific knockouts
of these genes – Rac1, Lpd and Fascin1 – are relatively mild (Li
et al., 2011; Law et al., 2013). This implies that melanoblast
epidermal migration is probably not strictly an invasive process, as it
does not absolutely require these cytoskeletal/motility factors or
extracellular matrix degradation activity through matrix
metalloproteases (Li et al., 2011; Ma et al., 2013). Work is also
required to link the chemokinetic effect of Kit-ligand and its
downstream activation of RAS/MAPK and AKT with the cell
biology of melanoblast proliferation and migration through
regulation of the cytoskeleton.
Post-migratory behaviour
In mice, the colonisation of the developing epidermis by
melanoblasts is complete by E15.5, by which point the primary
hair follicle pattern is also established and the secondary pattern is
beginning to form (Mann, 1962). FromE15.5 onwardsmelanoblasts
begin to colonise the developing hair follicles, and pigment
production (see Box 1) then begins at E16.5 (Hirobe, 1984). Little
is known about the molecular pathways that control hair follicle
localisation but the chemokine SDF-1/CXCL12 has been shown to
act as a chemoattractant for melanoblasts through its receptor
CXCR4 (Belmadani et al., 2009), whilst soluble KITL has been
shown to act as a chemokinetic factor (Jordan and Jackson, 2000).
Moving to follicles is associated with a switch from E-cadherin-
high/P-cadherin-low to E-cadherin-negative/P-cadherin-medium-
high to reflect the cadherin profile of the surrounding keratinocyte
environment (Nishimura et al., 1999), suggesting that cell-extrinsic
cues are important in regulating the cadherin expression of
melanoblasts and that cadherins play a role in positioning
melanoblasts in follicles. In early postnatal mice, a follicular and
an inter-follicular melanoblast population exists, but in hairy skin,
the expression of KITL by keratinocytes declines rapidly after birth
and, consequently, the inter-follicular population of melanoblasts
disappears a few days after birth, so that none are present in the adult
(Hirobe, 1984). In humans, the interfollicular population persists
and transfers melanin to the surrounding keratinocytes, thereby
pigmenting the skin.
Melanocyte development in zebrafish
In zebrafish, melanocytes are one of three pigment cell types –
melanocytes, iridophores and xanthophores – that form the famous
zebrafish stripes. Zebrafish melanocytes arise from a small number
of bipotent melanogenic progenitors that are derived directly from
the neural crest without a stem cell intermediate during the first three
days of development, and from another population that arises via an
MSC intermediate (Budi et al., 2011; Dooley et al., 2013; Hultman
et al., 2009; Tryon et al., 2011). Evidence of these populations can be
clearly distinguished during the patterning of the embryonic and
adult stages, and by genetic mutations, some of which give rise to
normal embryonic patterns but deficient adult patterns or vice versa
(Parichy, 2003). The first wave of melanocytes (referred to as
embryonic melanocytes) arises directly from the neural crest and
patterns the zebrafish during its embryonic stages by giving rise to
four stripes: the dorsal larval stripe, lateral larval stripe, ventral larval
stripe and yolk sac stripe (Fig. 2B). These melanocytes traverse a
dorsolateral migration pathway between the somites and epidermis
to contribute to the larval stripes, as well as a ventromedial pathway,
whereby melanoblasts traverse along nerves to contribute to the
lateral, ventral and yolk sac stripes (Dooley et al., 2013). As in
mammalian melanocytes, KIT functions in the this first wave of
melanocytes through distinct pathways, first promoting migration
during the first two days of development via its extracellular Ig
domains, followed by survival signalling via its cytoplasmic
tyrosine kinase domains (Rawls and Johnson, 2003).
Another set of melanocytes then develops in the later stages of
larval development and during the transition to an adult zebrafish
body shape (metamorphosis) to generate the adult stripes (Hultman
and Johnson, 2010). An important series of assays to study these
metamorphic or MSC-derived melanocytes in the embryo and adult
stages were developed by the Johnson lab, and included the
identification of melanocytotoxic small molecules to selectively
ablate differentiated melanocytes (Hultman et al., 2009; Rawls and
Johnson, 2000; Yang et al., 2004; Yang and Johnson, 2006;
O’Reilly-Pol and Johnson, 2008). These studies allow us to infer
that melanocyte regeneration following ablation in the embryo
occurs from an MSC, the establishment of which is dependent on
ERB and KIT signalling (Hultman et al., 2009; Yang and Johnson,
2006; O’Reilly-Pol and Johnson, 2013). Crucially, both embryos
treated with an ERB inhibitor in the first few days of development
and erbb3 mutants are defective for both the adult and regenerative
melanocytes, suggesting that the MSC population used during
regeneration is the same population of cells that generates the adult
stripe melanocytes (Budi et al., 2011; Hultman et al., 2009; Hultman
and Johnson, 2010). In the adult fin, melanocytes arise from stem
cells located at the base of the fin (Tu and Johnson, 2010).
Given the evidence supporting a population of MSCs in the adult
zebrafish, the Parichy laboratory undertook studies to successfully
identify cells in the adult zebrafish that express neural crest and
melanocyte markers (Budi et al., 2011). These extra-hypodermal
cells express the mitfa-GFP transgenic marker, are dependent on
ERB signalling and directly contribute to the adult melanocyte
pattern (Budi et al., 2011). Interestingly, these mitfa-GFP positive
cells are associated with peripheral nerves and ganglia, including
the dorsal root ganglia (DRG), ventral motor root fibres lateral line
nerves and nerves traversing through the myotome.
An advantage of the zebrafish system is its accessibility to whole-
embryo live imaging. To identify MSCs in the zebrafish embryo,
Dooley and colleagues from the Nüsslein-Volhard laboratory
performed whole-embryo live imaging to demonstrate that a small
number of melanoblasts maintain mitfa-GFP transgene expression
at three days of development, at a time when mitfa-GFP transgene
expression is normally reduced in differentiated melanocytes, and
that these cells contribute to the adult stripes (Dooley et al., 2013).
These cells are round and are closely associated with the DRG.
Mitfa-GFP-positive cells are also associated with the ventral spinal
nerves, and the authors note that their elongated shape is suggestive
of Schwann cells (Dooley et al., 2013). However, it should be noted
that MITF activity itself is not required for MSC establishment
because loss of MITFa activity during embryogenesis (by
morpholino or a mitfa temperature-sensitive mutant allele) still
allows full recovery of larval and adult stripe patterns (Dooley et al.,
2013; Johnson et al., 2011). The DRG-associated cells are
stationary, but, if MITF activity is restored, these cells can
proliferate and generate chains of melanoblasts that travel along
the peripheral nerves and migrate into the skin (Dooley et al., 2013).
Dooley and colleagues thus propose that the DRG is theMSC niche,
and that KIT signalling is crucial to recruit and maintain these cells
within the niche. The effects of ablating these MSCs are long
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lasting, and treatment with an ERB inhibitor during the first few
days of development in the embryo prevents the future development
of adult melanocytes (Budi et al., 2011; Dooley et al., 2013;
Hultman et al., 2009). Recent lineage-tracing and live-imaging
studies from the Nüsslein-Volhard laboratory indicate that
iridophores and melanophores originate from a shared niche at the
DRG, and that, having followed the tracts of peripheral nerves to
the skin, the melanoblasts then migrate in the skin until they reach
the stripe, differentiate into melanocytes and grow dramatically in
size (Singh et al., 2014).
Little is known about the regulation of the dramatic pigmentation
changes that occur during zebrafish metamorphosis. Given the role
of thyroid hormone (TH) in metabolism and growth, the Parichy
laboratory hypothesised that adult pigment patterns might be under
hormonal control (McMenamin et al., 2014). They discovered that a
genetic activating mutation in thyroid stimulating hormone receptor
(tshr) leads to a loss of melanocytes and an increase in yellow
xanthophores, whereas targeted genetic ablation of the thyroid, or
genetic loss of function mutation in tshr, leads to an increase in
melanocytes and loss of xanthophores. Notably, ablation of TH in
adult fish with established stripes lead to an increase in melanocyte
numbers, indicating that TH plays an active role in repressing
homeostatic melanocyte numbers. This might be relevant for
melanoma because hypothyroidism patients are at increased risk for
melanoma (Shah et al., 2006).
Mammalian MSCs
Returning tomammalianmelanocytes, oncemelanocyte development
and migration are established, how do animals maintain, alter or
regenerate pigmentation in adult life? Evidence frommultiple species
points to a reservoir of MSCs that can be called upon when needed to
re-pigment the skin and/or hair (Fig. 3). The identification and
potential manipulation of MSCs might hold therapeutic value for
pigmentation disorders, wounding and melanoma.
Melanocyte reservoirs in the skin and hair
The concept of a reservoir of undifferentiated melanocytes that
becomes activated to replenish depleted melanocytes comes from
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Fig. 3. Melanocyte stem cells in ageing and disease. (A) Melanocyte stem cells (MSCs; pink circles) associated with the hair follicle provide pigmented cells to
the growing hair. These follicular MSCs reside in the bulge region of the hair follicle and are supported in a niche by hair follicle stem cells (blue). Differentiated
melanocytes (black) reside at the bulb to pigment the growing hair. Aging or genotoxicity lead to the ectopic differentiation of MSCs in the follicular niche,
resulting in a loss of the MSC pool and hence loss of pigmentation of the hair. This gives rise to grey hair, as illustrated in the image of a mouse (far right), in which
genotoxic stress caused by ionizing radiation has induced hair greying [image courtesy of Emi Nishimura (Tokyo Medical and Dental University, Tokyo, Japan)].
The follicular MSCs also act as a reservoir for epidermal melanocytes in vitiligo patients, such thatmelanocytes from theMSC populationmigrate (indicated by red
arrows) to the skin. This results in the patches of pigmented skin associated with hair follicles that are observed in vitiligo patients, as illustrated in the image on the
right. [Image from Grichnik (2008) with permission.] (B) MSCs (pink circles) have also been identified in the sweat glands of volar skin and can contribute to the
epidermal melanocyte population (black). The sweat gland can also provide a niche for melanoma-initiating cells (black), which explains the ‘parallel ridge pattern’
of acral melanoma cells at the sweat gland [illustrated in the image on the far right; image from Saida et al. (2002) with permission]. Schematic images adapted
from Nishimura (2011); Zabierowski et al. (2011).
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initial observations in vitiligo patients (Nishimura, 2011). Vitiligo is
a condition that is characterised by a loss of melanocytes and
associated pigmentation in the skin and hair. In the early stages of
vitiligo, narrow-band UVB therapy can stimulate repigmentation to
give rise to tiny islands of pigmentation that eventually become
joined to form patches of uniform pigmentation (Fig. 3A). These
islands have a hair follicle at their centre, suggesting that
melanocytes from the follicle are the source of the new skin
melanocytes. Indeed, early studies (Nishimura, 2011; Staricco,
1959, 1963) identified a population of cells in the outer root sheath
of the lower permanent portion of the hair follicle that lacks melanin
(i.e. is amelanotic) and that becomes activated following UV
irradiation or epidermal wounding, and hence acts as a reservoir for
skin melanocytes (Cui et al., 1991). Whilst evidence for a
melanocyte reservoir in the human hair follicle was emerging, a
similar reservoir was also becoming apparent in mice. KIT is
required for the survival of melanocytes, so administering a mouse
with anti-KIT antibody leads to hair greying by inhibiting
melanocyte proliferation and differentiation (Botchkareva et al.,
2001). Subsequent hairs, however, are pigmented, indicating that a
KIT-independent progenitor population resides in the hair follicle
(Botchkareva et al., 2001). A crucial finding came from Nishimura
and colleagues, who identified this KIT-independent population as
the MSCs (Nishimura et al., 2002).
More recent studies show that, during development, and once at
the hair follicle, some melanoblasts differentiate to pigment the first
hair cycle, whereas others remain associated with the bulge region
and hair stem cells, reduce their expression of Mitf and become
quiescent MSCs until activated in the following hair cycle
(Nishimura, 2011). These quiescent MSCs reside in the lower
permanent portion of the hair follicle as undifferentiated, slow-
cycling melanoblasts (Fig. 3A), marked by expression of aDct:lacZ
transgene, and provide the hair matrix with amplifying and
differentiating melanocytes for that hair unit. There are no
markers unique to these MSCs, but they are characterised by their
cellular shape and location within the hair follicle, their low
proliferative rate and their low levels of KIT and MITF expression
(Nishimura et al., 2002; Ueno et al., 2014). Transcriptomic analysis
suggests that these cells have very low transcription rates and are in a
quiescent state, only to be stimulated to initiate gene expression and
cellular activity at the beginning of the hair follicle growth stage
(anagen) (Osawa et al., 2005; Freter et al., 2010).
Experimental evidence indicates that the MSCs in mice can
function in a similar manner to the amelanotic population in the
lower permanent portion of the human hair follicle. Unlike
human skin, the hairy skin of the mouse does not contain
melanocytes and does not express Kitl. However, the ectopic,
transgenic expression of Kitl by keratinocytes enables the survival
of melanocytes in the mouse skin, providing an opportunity to
generate mice with melanocytes in the hair and skin (Kunisada
et al., 1998), as in humans. As mentioned above, treating neonatal
mice with a KIT-blocking antibody selectively eliminates KIT-
positive differentiating melanocytes while sparing the MSCs.
Therefore, at the next anagen hair follicle stage, the MSCs become
activated and generate differentiating, transit-amplifying daughters.
These melanocytes pigment the hair and, in transgenic mice
expressing KITL in the skin, are also able to migrate, survive and
pigment in the skin. Importantly, similar to repigmentation of
vitiligo patients, islands of melanocytes repopulate the skin from
the hair follicle, providing experimental evidence that the follicular
MSCs in the mouse can provide a reservoir for hair and skin
melanocytes (Nishimura et al., 2002).
Insights into the pathways that govern MSCs have also been
gained from studies of the visible grey hair pigmentation
phenotypes associated with defective MSCs. These include the
phenotypes that arise following perturbation of the BRAF and
CRAF kinases, which regulate cell cycle entry (Valluet et al., 2012),
BCL2, which controls survival (Nishimura et al., 2005; Mak et al.,
2006), and SOX10, which is required for maintenance within the
bulge and for replenishing differentiated melanocytes in the bulb
(Harris et al., 2013). Notch signalling is also important for the
maintenance of melanoblasts and MSCs, both during development
and in the adult (Moriyama et al., 2006; Schouwey et al., 2007;
Kumano et al., 2008; Aubin-Houzelstein et al., 2008). Notably, the
expression of Notch1 is sufficient to convert pigmented mature
primary human melanocytes to multipotent neural crest stem-like
cells, underscoring the importance of Notch signalling in
melanocyte programming (Zabierowski et al., 2011).
Once at the follicular niche, the transit-amplifying progeny of
MSCs can colonise neighbouring empty niches and become
MSCs for a new hair unit, or they can revert back to a quiescent
MSC state following selective ablation of the stem cell pool, for
example by irradiation or genotoxic drugs (Nishimura et al., 2002;
Ueno et al., 2014). In the niche, TGFβ plays a crucial role in
regulating the transition of MSCs into a quiescent state during the
hair cycle, acting by inhibiting differentiation (pigmentation)
gene expression and by initiating BCL2-dependent cell cycle
arrest (Nishimura et al., 2010). Within the bulge region, the MSCs
intimately interact with hair follicle stem cells (HFSCs) that are
anchored by collagen XVII and provide a functional MSC niche
(Fig. 3A). The two stem cell populations coordinate hair growth
with pigmentation via TGFβ and WNT signalling cross-talk
(Tanimura et al., 2011; Rabbani et al., 2011). Recent evidence
also implicates the transcription factor NFIB as a coordinator of
this cross-talk; inhibition of endothelin 2 by NFIB in HFSCs
prevents enhanced proliferation and precocious differentiation in
the MSCs (Chang et al., 2013).
Although much of our understanding about MSCs comes from
the hair follicle-associated MSCs, two additional sources of
melanocytes that are important for the identification of MSCs in
the skin are emerging. The Herlyn laboratory developed three-
dimensional (3D) reconstruction skin models from human
foreskin, which lacks hair follicles, and discovered that, when
dermal stem cells are embedded into dermis, a subpopulation
migrates to the basement membrane of the epidermis and
differentiates into melanocytes (Li et al., 2010b). Thus, dermal
stem cells might have the potential to replenish extra-follicular
epidermal melanocytes. Another source of melanocytes appears to
be in the sweat glands of acral volar skin in humans and mice
(Fig. 3B); the Nishimura laboratory recently identified the
secretory lower permanent portion of the sweat gland as a new
anatomical niche for MSCs that can provide the epidermis with
differentiated melanocytes (Okamoto et al., 2014). Crucially, this
niche can also maintain melanoma cells in an immature state,
which thus explains the characteristic dermoscopic ‘parallel ridge
pattern’ formed by acral melanoma cells (Okamoto et al., 2014)
(Fig. 3B).
MSC depletion in aging, disease and wounding
Despite their potential for renewal, MSCs are a limited population.
A gradual decline in the number of follicular MSCs during
physiological aging results in hair greying in both humans and mice
(Nishimura et al., 2005). MSCs in zebrafish also have the potential
for repeated renewal after sequential ablation, and, although
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zebrafish do not ‘go grey’, these MSCs can eventually become
depleted, resulting in loss of hypodermal melanocyte stripes (Budi
et al., 2011).
Although little is known about MSC depletion in zebrafish or
chick, work from Nishimura and colleagues demonstrate that the
physiological depletion of MSCs in the niche is accompanied by
cellular differentiation (Nishimura et al., 2005). In older mice and
humans, ectopically pigmented (differentiated) melanocytes
(EPM) become apparent at the bulge region of the outer root
sheath and are associated with the loss of MSCs (Nishimura et al.,
2005). MSC depletion is also observed in hair greying induced by
DNA damage, such as that induced by X-rays or chemotherapeutic
drugs, but the response is distinct from the DNA damage pathway
that triggers apoptosis or senescence of other stem cell populations
(Inomata et al., 2009). Interestingly, this DNA damage pathway is
p53 independent and instead relies on an Ataxia-telangiectasia
mutated (ATM)MSC ‘stemness checkpoint’ (Inomata et al., 2009).
The appearance of EPMs following DNA damage suggests that
EPMs seen in aging individuals are caused by an accumulation of
DNA damage, and supports the idea that one of the major causes of
stem cell depletion is the accumulation of DNA damage over one’s
lifetime.
What about premature hair greying? In fact, individuals with
mutations in the DNA damage repair pathways, such as those
affected by premature aging syndrome, Werner’s syndrome (caused
by mutation in the ReqQ helicase WRN) or Ataxia-telangiectasia
(caused by mutation in ATM), do exhibit premature hair greying
(see Box 2), indicating that the DNA damage response is important
for maintaining stem cell renewal. Premature hair greying, without
aging in other systems, is observed in patients carrying MITF
mutations and in the mouse Mitfvitiligo mutation. These examples
from human and mouse genetics indicate that, despite being
expressed at low levels in the MSC, MITF is important for
maintaining the stem cell pool. It is tempting to speculate that this
might be linked to the DNA damage response, because EPMs are
observed following DNA damage induced by prolonged expression
of the melanogenic genes regulated by MITF (Inomata et al., 2009),
and because MITF directly regulates DNA damage repair genes in
melanoma (Giuliano et al., 2010; Strub et al., 2011). It will also be
interesting to determine whether EPMs are able to play a role in
preventing melanoma by removing damaged stem cells.
MSCs also have the potential to leave the niche. Recent
experiments reveal that MSCs themselves, rather than
proliferating daughter cells, migrate out of the hair follicle niche
in an MC1R-dependent process to provide a source of melanocytes
in mouse skin during wound repair or following UV-irradiation
(Chou et al., 2013). Notably, in the context of wound repair, the
migration of MSCs from the niche can be so drastic that it empties
the hair follicle niche, resulting in white hairs (Chou et al., 2013).
However, wound-induced epidermal melanocytes – those that seem
to be able to produce pigment in the skin – can be recruited to newly
forming hair follicles to take their place as MSCs (Chou et al.,
2013). Wounds can also be associated with hyperpigmentation, and
this could be because the wound-healing process produces a
chemokine that attracts melanocytes (Chou et al., 2013), or it could
suggest a non-canonical function for melanocytes in wound repair.
In zebrafish, wounding induces hyperpigmentation by recruiting
melanoblasts and melanocytes to the wound site, and this is
dependent on the activity of macrophages and neutrophils at the
wound (Levesque et al., 2013). In mammals, communication
between macrophages and melanocytes in response to UV (Zaidi
et al., 2011), together with the existence of macrophage-like
melanocytes that reside in the perivasculature (Zhang et al., 2012,
2013) and respond to inflammation (Bald et al., 2014), provide
additional evidence that melanocytes might have the potential to do
more than just colouring skin and hair cells.
The melanocyte lineage in melanoma
One of themost deadly andmetastatic forms of cancer ismelanoma –
cancer of the melanocyte. Clues to melanoma therapies come from
directly understanding melanocyte development. Indeed, there are
an increasing number of examples that show correlations between
genes that regulate neural crest/melanocyte development and those
that contribute to melanoma (Shakhova, 2014; White and Zon,
2008). Understanding the ontogeny and biology of melanocytes –
their development from stem and progenitor cells, their
proliferation, migration, differentiation, regeneration and death,
and their interactions with their environment – might be highly
informative for generating new therapeutic approaches to
pigmentation disorders and melanoma.
Activating mutations in BRAF are among the most frequent
mutations in melanoma, and somatic mutations have also been
identified in genes encoding the transcriptional machinery that drives
neural crest and melanocyte development. For example, a link
betweenMITF andmelanomawas first established by histopathology
in human melanoma, and many MITF molecular mechanisms and
target genes in melanoma have subsequently been revealed (Cheli
et al., 2010; Tsao et al., 2012). The expression ofMITF can lead to the
expression of cell cycle genes that both promote and inhibitmelanoma
progression, implying a ‘rheostat model’ in which MITF alters
expression of different target genes, depending on its expression and
activity level. At the most basic level of this idea, high levels ofMITF
function to promote melanocyte differentiation and cell cycle arrest,
Box 2. Premature greying syndromes
Hair pigmentation is one of the most striking phenotypes in humans.
Most humans begin to show grey hair at about 35 years of age, but some
people develop grey hair prematurely – before 20 years in Europeans,
25 years in Asians and 30 years in Africans (McDonough and Schwartz,
2012; Pandhi and Khanna, 2013). The aetiology of premature hair
greying is not always known, but it can be symptomatic of underlying
autoimmune disorders such as vitiligo, or endocrine disorders such as
hypothyroidism (McDonough and Schwartz, 2012; Pandhi and Khanna,
2013). Genetic conditions affecting melanocyte biology, including
Waardenburg Type II syndrome and Tietz syndrome (caused by
mutations in MITF and SOX10), are also characterised in part by
premature hair greying and, as with physiological hair greying, the
greying is associated with a loss of melanocytes (Tassabehji et al.,
1995). Premature hair greying also features in segmental progeroid
syndromes, rare genetic syndromes of accelerated aging of multiple
organs and tissues, including dyskeratosis congenital (which is caused
by mutations in TERT), Hutchinson–Gilford progeria syndrome (which
involves mutations in Lamin A/C) or syndromes caused by defective
DNA repair, such as Werner syndrome, Cockayne syndrome or
xeroderma pigmentosum (Sahin and Depinho, 2010). Environmental
factors, such as UV light (Trueb, 2006), smoking (Mosley and Gibbs,
1996) and oxidative stress (Shi et al., 2014; Wood et al., 2009;
Kamenisch and Berneburg, 2009) might also contribute to premature
hair greying, possibly through an increase in intracellular reactive oxygen
species. Nutritional deficiencies in trace elements (Fatemi Naieni et al.,
2012), including vitamin D3 (Bhat et al., 2013), vitamin B12 (such as in
pernicious anaemia) and copper (such as in Menkes disease) can also
lead to hair greying. These conditions are thought to reflect deficiencies
in the pigmentation pathway rather than loss of melanocytes, such that
colour can be restored with nutritional supplementation (Heath and
Sidbury, 2006).
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whereas lower levels of MITF activity activate the cell cycle without
promoting the expression of pigmentation genes (Hoek and Goding,
2010). Interestingly, the MITF mutations that are associated with
Waardenburg and Tietz syndromes are distinct from those that are
found in melanoma: Waardenburg and Tietz syndrome MITF
mutations primarily alter the DNA-binding properties of MITF and
inactivate its transcriptional activity, whereas melanoma MITF
mutations confer altered transcriptional activity upon MITF (Grill
et al., 2013; Cronin et al., 2009). For example, the expression ofMITF
harbouring the melanoma-associated MITF4TΔ2B mutation in
zebrafish does not inhibit the specification or differentiation of
melanocytes but instead allows the continued proliferation of
differentiated melanocytes during development (Taylor et al.,
2011). It was also shown that, in zebrafish, a hypomorphic mitfa
mutation cooperates with oncogenic BRAF to promote superficial
spreading melanoma (Lister et al., 2014). Furthermore, in horses, a
mutation in MITF causes premature hair greying coupled with
melanoma (Curik et al., 2013; Rosengren Pielberg et al., 2008).MITF
is expressed in both melanocytes and the kidney, and a germline
mutation in human MITF that predisposes to melanoma and kidney
cancer has recently been found. This MITF318K mutation leads to
altered MITF activity and, although the transcription of some
melanogenic genes remains unchanged, one consequence of the
mutation is transcription of hypoxia-inducible factor 1-alpha (HIF1-
α), which provides a growth advantage to cancer cells (Bertolotto
et al., 2011; Ghiorzo et al., 2013; Yokoyama et al., 2011).
Links between SOX10 and melanoma have also been identified
and, as such, SOX10might be an effective target for melanoma and
for giant congenital nevi, which are benign melanocyte-containing
skin lesions that can sometimes develop into melanoma. Sommer
and colleagues noticed similar histopathological features between
children with giant congenital nevi and mice that express activated
N-RAS in melanocytes: both have nests of pigmented nevus cells
in the dermis without apparent epidermal involvement, and
both human and mouse nevi melanocytes express higher levels
of Sox10 than control melanocytes (Shakhova et al., 2012). Loss of
the melanoma tumour suppressor INK4A (CDKN2A – HUGO
Gene Nomenclature Committee) leads to rapid melanoma
formation in activated N-RAS-expressing mice and, in a
remarkable genetic experiment, it was shown that the loss of one
allele of Sox10 is sufficient to counteract activated N-RAS
hyperpigmentation and melanoma (Shakhova et al., 2012).
Similar findings by the Pavan laboratory demonstrate that SOX10
haploinsufficiency prevents melanoma formation in a Grm1-
transgenic mouse melanoma model (Cronin et al., 2013).
Understanding the downstream effectors of lineage-specific
programmes in melanoma will be crucial. In a recent example,
Soengas and colleagues identified RAB7 as a new regulator of
melanoma progression and showed this to be specifically wired
into the melanoma lineage by the transcription factors SOX10 and
MYC (Alonso-Curbelo et al., 2014).
The dependence of melanoma and nevi on melanocyte
developmental factors might be an exploitable feature in the
clinic. Sox10 haploinsufficiency in mice can lead to tumour
regression in an already established nevus, and in zebrafish,
turning off MITF activity in an established melanoma leads to
rapid tumour regression (Lister et al., 2014; Shakhova et al., 2012).
Furthermore, recent genomic analyses of human melanomas have
revealed that MITF and a melanocyte lineage-specific programme
are especially important in drug-resistant melanomas, suggesting
that MITF is involved in drug-resistance mechanisms (Johannessen
et al., 2013).
Conclusions
In recent years, great progress has been made in understanding the
molecular events that lead a neural crest cell to become a
melanocyte, how these melanocytes are maintained during
homeostasis, and how melanocytes respond to their environment.
The interplay between transcription factors resulting in expression
of the ‘master regulator’ MITF is being explored, and some
knowledge exists of the roles played by SOX10, PAX3, FOXD3,
SOX2, SOX9, ZIC3 and SNAIL2. There appear to be mechanistic
differences between, for example, chick and zebrafish, and it
remains to be seen whether these are real species-dependent features
or whether they simply reflect differences in experimental
approaches. Some of the extrinsic factors that determine or guide
melanocyte differentiation, such asWNT3A, KIT-ligand and EDN3
(the ligand of EDNRB), have also been identified but there might
well be more to find. In particular, thyroid-stimulating hormone has
been shown to participate in zebrafish pigment cell development but
has not, as yet, been directly implicated in melanocyte development
in other vertebrates.
The recent findings that melanocytes can arise from neural crest
cells on a ventral migratory pathway, which can be identified as
Schwann cell progenitors by their gene expression, are provocative.
Certainly, melanocytes in zebrafish can arise from precursors
migrating along nerves, and in chick, a dual origin, depending on
the mesodermal source of the dermis, has been demonstrated.
Establishing the degree to which these novel progenitors contribute
to functional melanocytes in mice probably needs the development
of better lineage-restricted Cre-driver mice.
The biology of MSCs in various species has also been well
examined recently. In mice, much of the work has focussed on the
readily identifiable stem cells present in the hair follicle and, latterly,
those in the sweat glands. It is likely, however, that there are also
stem cells in the interfollicular epidermis that remain to be found.
Any roles for these stem cells in melanoma formation and/or in
vitiligo might point the way to future therapies for these diseases.
Overall, understanding the ontogeny and biology of melanocytes
will undoubtedly be highly informative for developing new
therapeutic approaches to pigmentation disorders and melanoma.
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